Global Dent Disease Treatment Market

Dent Disease Treatment Comprehensive Study by Drug Type (Calcium Phosphate, Cysteine, Angiotensin-Converting Enzyme (ACE) Inhibitor, Angiotensin Receptor Blockers, Uric Acid, Calcium Oxalate, Thiazide Diuretics, Others), Disease Type (Dent Disease Type 1, Dent Disease Type 2), Treatment Type (Ureteroscopy, Percutaneous Nephrolithotomy, Extracorporeal Shock Wave Lithotripsy (ESWL)), End User (Hospitals, Diagnostic centers, Laboratories, Others) Players and Region - Global Market Outlook to 202

Dent Disease Treatment Market by XX Submarkets | Forecast Years 2023-202  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Dent Disease Treatment
Dent disease treatment offers treatment to rare genetic kidney disorders. To reduce the quantity of calcium in the urine and to decrease the recurrent occurrence of nephrolithiasis, dent disease treatment plays an important role. Additionally, dent disease treatment cures the kidney calcifications which also known as nephrocalcinosis. In some cases, the dent disease will gradually worsen and causes severe kidney disease. Dent disease affects exclusively males as compared to females.

AttributesDetails
Study Period2018-202
Base Year2022
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Dent Disease Treatment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Boston Scientific Corporation (United States), Medispec LTD (United States), Elmed Medical Systems Inc (Turkey), Dornier MedTech (Germany), Richard Wolf GmbH (Germany), DirexGroup (United States), Cook Medical LLC. (United States), Stryker Corporation (United States) and Medtronic plc (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Dent Disease Treatment market by and Region.



On the basis of geography, the market of Dent Disease Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Drug Type, the sub-segment i.e. Calcium Phosphate will boost the Dent Disease Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Disease Type, the sub-segment i.e. Dent Disease Type 1 will boost the Dent Disease Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Treatment Type, the sub-segment i.e. Ureteroscopy will boost the Dent Disease Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Dent Disease Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing as the Escalating Incidence of Kidney Disorder

Market Growth Drivers:
Increasing Inclination Towards the Treatment of Chronic Kidney Disorder and Rising Prevalence of Gene Mutation with Growing Awareness about Alternative Therapy Approach

Challenges:
Lack of Skilled Professionals

Restraints:
Lack of Ideal Specific Treatment for Dent Disease

Opportunities:
Increasing Number of Co-Development Agreements and Collaboration of major Pharmaceuticals Company with Regional Distributors

Market Leaders and their expansionary development strategies
In July 2023, PTC Therapeutics and Cure Dent Disease has Announced a multi-year collaboration to develop and commercialize PTC's investigational gene therapy, PTC-AADC, for the treatment of Dent disease. This collaboration leverages PTC's expertise in gene therapy development with Cure Dent Disease's patient advocacy and clinical trial expertise.
In October 2023, ProQR Therapeutics has launched positive Phase 2 trial results for sepofarsen, an antisense oligonucleotide drug candidate for treating Dent disease. The study demonstrated that sepofarsen significantly improved proteinuria (excess protein in urine) in patients with Dent disease.


Key Target Audience
Dent Disease Treatment Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End-User and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Drug Type
  • Calcium Phosphate
  • Cysteine
  • Angiotensin-Converting Enzyme (ACE) Inhibitor
  • Angiotensin Receptor Blockers
  • Uric Acid
  • Calcium Oxalate
  • Thiazide Diuretics
  • Others

By Disease Type
  • Dent Disease Type 1
  • Dent Disease Type 2

By Treatment Type
  • Ureteroscopy
  • Percutaneous Nephrolithotomy
  • Extracorporeal Shock Wave Lithotripsy (ESWL)

By End User
  • Hospitals
  • Diagnostic centers
  • Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Inclination Towards the Treatment of Chronic Kidney Disorder
      • 3.2.2. Rising Prevalence of Gene Mutation with Growing Awareness about Alternative Therapy Approach
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Increasing as the Escalating Incidence of Kidney Disorder
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dent Disease Treatment, by Drug Type, Disease Type, Treatment Type, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Dent Disease Treatment (Value)
      • 5.2.1. Global Dent Disease Treatment by: Drug Type (Value)
        • 5.2.1.1. Calcium Phosphate
        • 5.2.1.2. Cysteine
        • 5.2.1.3. Angiotensin-Converting Enzyme (ACE) Inhibitor
        • 5.2.1.4. Angiotensin Receptor Blockers
        • 5.2.1.5. Uric Acid
        • 5.2.1.6. Calcium Oxalate
        • 5.2.1.7. Thiazide Diuretics
        • 5.2.1.8. Others
      • 5.2.2. Global Dent Disease Treatment by: Disease Type (Value)
        • 5.2.2.1. Dent Disease Type 1
        • 5.2.2.2. Dent Disease Type 2
      • 5.2.3. Global Dent Disease Treatment by: Treatment Type (Value)
        • 5.2.3.1. Ureteroscopy
        • 5.2.3.2. Percutaneous Nephrolithotomy
        • 5.2.3.3. Extracorporeal Shock Wave Lithotripsy (ESWL)
      • 5.2.4. Global Dent Disease Treatment by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Diagnostic centers
        • 5.2.4.3. Laboratories
        • 5.2.4.4. Others
      • 5.2.5. Global Dent Disease Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Dent Disease Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boston Scientific Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medispec LTD (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Elmed Medical Systems Inc (Turkey)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Dornier MedTech (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Richard Wolf GmbH (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. DirexGroup (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cook Medical LLC. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Stryker Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medtronic plc (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Dent Disease Treatment Sale, by Drug Type, Disease Type, Treatment Type, End User and Region (value) (197-202)
    • 7.1. Introduction
    • 7.2. Global Dent Disease Treatment (Value)
      • 7.2.1. Global Dent Disease Treatment by: Drug Type (Value)
        • 7.2.1.1. Calcium Phosphate
        • 7.2.1.2. Cysteine
        • 7.2.1.3. Angiotensin-Converting Enzyme (ACE) Inhibitor
        • 7.2.1.4. Angiotensin Receptor Blockers
        • 7.2.1.5. Uric Acid
        • 7.2.1.6. Calcium Oxalate
        • 7.2.1.7. Thiazide Diuretics
        • 7.2.1.8. Others
      • 7.2.2. Global Dent Disease Treatment by: Disease Type (Value)
        • 7.2.2.1. Dent Disease Type 1
        • 7.2.2.2. Dent Disease Type 2
      • 7.2.3. Global Dent Disease Treatment by: Treatment Type (Value)
        • 7.2.3.1. Ureteroscopy
        • 7.2.3.2. Percutaneous Nephrolithotomy
        • 7.2.3.3. Extracorporeal Shock Wave Lithotripsy (ESWL)
      • 7.2.4. Global Dent Disease Treatment by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Diagnostic centers
        • 7.2.4.3. Laboratories
        • 7.2.4.4. Others
      • 7.2.5. Global Dent Disease Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dent Disease Treatment: by Drug Type(USD Million)
  • Table 2. Dent Disease Treatment Calcium Phosphate , by Region USD Million (2017-2022)
  • Table 3. Dent Disease Treatment Cysteine , by Region USD Million (2017-2022)
  • Table 4. Dent Disease Treatment Angiotensin-Converting Enzyme (ACE) Inhibitor , by Region USD Million (2017-2022)
  • Table 5. Dent Disease Treatment Angiotensin Receptor Blockers , by Region USD Million (2017-2022)
  • Table 6. Dent Disease Treatment Uric Acid , by Region USD Million (2017-2022)
  • Table 7. Dent Disease Treatment Calcium Oxalate , by Region USD Million (2017-2022)
  • Table 8. Dent Disease Treatment Thiazide Diuretics , by Region USD Million (2017-2022)
  • Table 9. Dent Disease Treatment Others , by Region USD Million (2017-2022)
  • Table 10. Dent Disease Treatment: by Disease Type(USD Million)
  • Table 11. Dent Disease Treatment Dent Disease Type 1 , by Region USD Million (2017-2022)
  • Table 12. Dent Disease Treatment Dent Disease Type 2 , by Region USD Million (2017-2022)
  • Table 13. Dent Disease Treatment: by Treatment Type(USD Million)
  • Table 14. Dent Disease Treatment Ureteroscopy , by Region USD Million (2017-2022)
  • Table 15. Dent Disease Treatment Percutaneous Nephrolithotomy , by Region USD Million (2017-2022)
  • Table 16. Dent Disease Treatment Extracorporeal Shock Wave Lithotripsy (ESWL) , by Region USD Million (2017-2022)
  • Table 17. Dent Disease Treatment: by End User(USD Million)
  • Table 18. Dent Disease Treatment Hospitals , by Region USD Million (2017-2022)
  • Table 19. Dent Disease Treatment Diagnostic centers , by Region USD Million (2017-2022)
  • Table 20. Dent Disease Treatment Laboratories , by Region USD Million (2017-2022)
  • Table 21. Dent Disease Treatment Others , by Region USD Million (2017-2022)
  • Table 22. South America Dent Disease Treatment, by Country USD Million (2017-2022)
  • Table 23. South America Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 24. South America Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 25. South America Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 26. South America Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 27. Brazil Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 28. Brazil Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 29. Brazil Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 30. Brazil Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 31. Argentina Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 32. Argentina Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 33. Argentina Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 34. Argentina Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 35. Rest of South America Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 36. Rest of South America Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 37. Rest of South America Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 38. Rest of South America Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 39. Asia Pacific Dent Disease Treatment, by Country USD Million (2017-2022)
  • Table 40. Asia Pacific Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 41. Asia Pacific Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 42. Asia Pacific Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 43. Asia Pacific Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 44. China Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 45. China Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 46. China Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 47. China Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 48. Japan Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 49. Japan Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 50. Japan Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 51. Japan Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 52. India Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 53. India Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 54. India Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 55. India Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 56. South Korea Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 57. South Korea Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 58. South Korea Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 59. South Korea Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 60. Taiwan Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 61. Taiwan Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 62. Taiwan Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 63. Taiwan Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 64. Australia Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 65. Australia Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 66. Australia Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 67. Australia Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 71. Rest of Asia-Pacific Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 72. Europe Dent Disease Treatment, by Country USD Million (2017-2022)
  • Table 73. Europe Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 74. Europe Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 75. Europe Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 76. Europe Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 77. Germany Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 78. Germany Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 79. Germany Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 80. Germany Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 81. France Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 82. France Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 83. France Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 84. France Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 85. Italy Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 86. Italy Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 87. Italy Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 88. Italy Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 89. United Kingdom Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 90. United Kingdom Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 91. United Kingdom Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 92. United Kingdom Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 93. Netherlands Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 94. Netherlands Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 95. Netherlands Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 96. Netherlands Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 97. Rest of Europe Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 98. Rest of Europe Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 99. Rest of Europe Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 100. Rest of Europe Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 101. MEA Dent Disease Treatment, by Country USD Million (2017-2022)
  • Table 102. MEA Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 103. MEA Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 104. MEA Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 105. MEA Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 106. Middle East Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 107. Middle East Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 108. Middle East Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 109. Middle East Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 110. Africa Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 111. Africa Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 112. Africa Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 113. Africa Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 114. North America Dent Disease Treatment, by Country USD Million (2017-2022)
  • Table 115. North America Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 116. North America Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 117. North America Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 118. North America Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 119. United States Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 120. United States Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 121. United States Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 122. United States Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 123. Canada Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 124. Canada Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 125. Canada Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 126. Canada Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 127. Mexico Dent Disease Treatment, by Drug Type USD Million (2017-2022)
  • Table 128. Mexico Dent Disease Treatment, by Disease Type USD Million (2017-2022)
  • Table 129. Mexico Dent Disease Treatment, by Treatment Type USD Million (2017-2022)
  • Table 130. Mexico Dent Disease Treatment, by End User USD Million (2017-2022)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Dent Disease Treatment: by Drug Type(USD Million)
  • Table 141. Dent Disease Treatment Calcium Phosphate , by Region USD Million (197-202)
  • Table 142. Dent Disease Treatment Cysteine , by Region USD Million (197-202)
  • Table 143. Dent Disease Treatment Angiotensin-Converting Enzyme (ACE) Inhibitor , by Region USD Million (197-202)
  • Table 144. Dent Disease Treatment Angiotensin Receptor Blockers , by Region USD Million (197-202)
  • Table 145. Dent Disease Treatment Uric Acid , by Region USD Million (197-202)
  • Table 146. Dent Disease Treatment Calcium Oxalate , by Region USD Million (197-202)
  • Table 147. Dent Disease Treatment Thiazide Diuretics , by Region USD Million (197-202)
  • Table 148. Dent Disease Treatment Others , by Region USD Million (197-202)
  • Table 149. Dent Disease Treatment: by Disease Type(USD Million)
  • Table 150. Dent Disease Treatment Dent Disease Type 1 , by Region USD Million (197-202)
  • Table 151. Dent Disease Treatment Dent Disease Type 2 , by Region USD Million (197-202)
  • Table 152. Dent Disease Treatment: by Treatment Type(USD Million)
  • Table 153. Dent Disease Treatment Ureteroscopy , by Region USD Million (197-202)
  • Table 154. Dent Disease Treatment Percutaneous Nephrolithotomy , by Region USD Million (197-202)
  • Table 155. Dent Disease Treatment Extracorporeal Shock Wave Lithotripsy (ESWL) , by Region USD Million (197-202)
  • Table 156. Dent Disease Treatment: by End User(USD Million)
  • Table 157. Dent Disease Treatment Hospitals , by Region USD Million (197-202)
  • Table 158. Dent Disease Treatment Diagnostic centers , by Region USD Million (197-202)
  • Table 159. Dent Disease Treatment Laboratories , by Region USD Million (197-202)
  • Table 160. Dent Disease Treatment Others , by Region USD Million (197-202)
  • Table 161. South America Dent Disease Treatment, by Country USD Million (197-202)
  • Table 162. South America Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 163. South America Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 164. South America Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 165. South America Dent Disease Treatment, by End User USD Million (197-202)
  • Table 166. Brazil Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 167. Brazil Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 168. Brazil Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 169. Brazil Dent Disease Treatment, by End User USD Million (197-202)
  • Table 170. Argentina Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 171. Argentina Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 172. Argentina Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 173. Argentina Dent Disease Treatment, by End User USD Million (197-202)
  • Table 174. Rest of South America Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 175. Rest of South America Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 176. Rest of South America Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 177. Rest of South America Dent Disease Treatment, by End User USD Million (197-202)
  • Table 178. Asia Pacific Dent Disease Treatment, by Country USD Million (197-202)
  • Table 179. Asia Pacific Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 180. Asia Pacific Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 181. Asia Pacific Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 182. Asia Pacific Dent Disease Treatment, by End User USD Million (197-202)
  • Table 183. China Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 184. China Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 185. China Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 186. China Dent Disease Treatment, by End User USD Million (197-202)
  • Table 187. Japan Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 188. Japan Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 189. Japan Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 190. Japan Dent Disease Treatment, by End User USD Million (197-202)
  • Table 191. India Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 192. India Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 193. India Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 194. India Dent Disease Treatment, by End User USD Million (197-202)
  • Table 195. South Korea Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 196. South Korea Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 197. South Korea Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 198. South Korea Dent Disease Treatment, by End User USD Million (197-202)
  • Table 199. Taiwan Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 200. Taiwan Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 201. Taiwan Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 202. Taiwan Dent Disease Treatment, by End User USD Million (197-202)
  • Table 203. Australia Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 204. Australia Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 205. Australia Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 206. Australia Dent Disease Treatment, by End User USD Million (197-202)
  • Table 207. Rest of Asia-Pacific Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 208. Rest of Asia-Pacific Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 209. Rest of Asia-Pacific Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 210. Rest of Asia-Pacific Dent Disease Treatment, by End User USD Million (197-202)
  • Table 211. Europe Dent Disease Treatment, by Country USD Million (197-202)
  • Table 212. Europe Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 213. Europe Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 214. Europe Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 215. Europe Dent Disease Treatment, by End User USD Million (197-202)
  • Table 216. Germany Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 217. Germany Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 218. Germany Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 219. Germany Dent Disease Treatment, by End User USD Million (197-202)
  • Table 220. France Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 221. France Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 222. France Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 223. France Dent Disease Treatment, by End User USD Million (197-202)
  • Table 224. Italy Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 225. Italy Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 226. Italy Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 227. Italy Dent Disease Treatment, by End User USD Million (197-202)
  • Table 228. United Kingdom Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 229. United Kingdom Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 230. United Kingdom Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 231. United Kingdom Dent Disease Treatment, by End User USD Million (197-202)
  • Table 232. Netherlands Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 233. Netherlands Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 234. Netherlands Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 235. Netherlands Dent Disease Treatment, by End User USD Million (197-202)
  • Table 236. Rest of Europe Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 237. Rest of Europe Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 238. Rest of Europe Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 239. Rest of Europe Dent Disease Treatment, by End User USD Million (197-202)
  • Table 240. MEA Dent Disease Treatment, by Country USD Million (197-202)
  • Table 241. MEA Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 242. MEA Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 243. MEA Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 244. MEA Dent Disease Treatment, by End User USD Million (197-202)
  • Table 245. Middle East Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 246. Middle East Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 247. Middle East Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 248. Middle East Dent Disease Treatment, by End User USD Million (197-202)
  • Table 249. Africa Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 250. Africa Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 251. Africa Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 252. Africa Dent Disease Treatment, by End User USD Million (197-202)
  • Table 253. North America Dent Disease Treatment, by Country USD Million (197-202)
  • Table 254. North America Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 255. North America Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 256. North America Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 257. North America Dent Disease Treatment, by End User USD Million (197-202)
  • Table 258. United States Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 259. United States Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 260. United States Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 261. United States Dent Disease Treatment, by End User USD Million (197-202)
  • Table 262. Canada Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 263. Canada Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 264. Canada Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 265. Canada Dent Disease Treatment, by End User USD Million (197-202)
  • Table 266. Mexico Dent Disease Treatment, by Drug Type USD Million (197-202)
  • Table 267. Mexico Dent Disease Treatment, by Disease Type USD Million (197-202)
  • Table 268. Mexico Dent Disease Treatment, by Treatment Type USD Million (197-202)
  • Table 269. Mexico Dent Disease Treatment, by End User USD Million (197-202)
  • Table 270. Research Programs/Design for This Report
  • Table 271. Key Data Information from Secondary Sources
  • Table 272. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dent Disease Treatment: by Drug Type USD Million (2017-2022)
  • Figure 5. Global Dent Disease Treatment: by Disease Type USD Million (2017-2022)
  • Figure 6. Global Dent Disease Treatment: by Treatment Type USD Million (2017-2022)
  • Figure 7. Global Dent Disease Treatment: by End User USD Million (2017-2022)
  • Figure 8. South America Dent Disease Treatment Share (%), by Country
  • Figure 9. Asia Pacific Dent Disease Treatment Share (%), by Country
  • Figure 10. Europe Dent Disease Treatment Share (%), by Country
  • Figure 11. MEA Dent Disease Treatment Share (%), by Country
  • Figure 12. North America Dent Disease Treatment Share (%), by Country
  • Figure 13. Global Dent Disease Treatment share by Players 2022 (%)
  • Figure 14. Global Dent Disease Treatment share by Players (Top 3) 2022(%)
  • Figure 15. Global Dent Disease Treatment share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Boston Scientific Corporation (United States) Revenue: by Geography 2022
  • Figure 19. Medispec LTD (United States) Revenue, Net Income and Gross profit
  • Figure 20. Medispec LTD (United States) Revenue: by Geography 2022
  • Figure 21. Elmed Medical Systems Inc (Turkey) Revenue, Net Income and Gross profit
  • Figure 22. Elmed Medical Systems Inc (Turkey) Revenue: by Geography 2022
  • Figure 23. Dornier MedTech (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Dornier MedTech (Germany) Revenue: by Geography 2022
  • Figure 25. Richard Wolf GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Richard Wolf GmbH (Germany) Revenue: by Geography 2022
  • Figure 27. DirexGroup (United States) Revenue, Net Income and Gross profit
  • Figure 28. DirexGroup (United States) Revenue: by Geography 2022
  • Figure 29. Cook Medical LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cook Medical LLC. (United States) Revenue: by Geography 2022
  • Figure 31. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Stryker Corporation (United States) Revenue: by Geography 2022
  • Figure 33. Medtronic plc (United States) Revenue, Net Income and Gross profit
  • Figure 34. Medtronic plc (United States) Revenue: by Geography 2022
  • Figure 35. Global Dent Disease Treatment: by Drug Type USD Million (197-202)
  • Figure 36. Global Dent Disease Treatment: by Disease Type USD Million (197-202)
  • Figure 37. Global Dent Disease Treatment: by Treatment Type USD Million (197-202)
  • Figure 38. Global Dent Disease Treatment: by End User USD Million (197-202)
  • Figure 39. South America Dent Disease Treatment Share (%), by Country
  • Figure 40. Asia Pacific Dent Disease Treatment Share (%), by Country
  • Figure 41. Europe Dent Disease Treatment Share (%), by Country
  • Figure 42. MEA Dent Disease Treatment Share (%), by Country
  • Figure 43. North America Dent Disease Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Boston Scientific Corporation (United States)
  • Medispec LTD (United States)
  • Elmed Medical Systems Inc (Turkey)
  • Dornier MedTech (Germany)
  • Richard Wolf GmbH (Germany)
  • DirexGroup (United States)
  • Cook Medical LLC. (United States)
  • Stryker Corporation (United States)
  • Medtronic plc (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 228 Pages 88 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Dent Disease Treatment Market Quantitative research analysis
Global Dent Disease Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Boston Scientific Corporation (United States), Medispec LTD (United States), Elmed Medical Systems Inc (Turkey), Dornier MedTech (Germany), Richard Wolf GmbH (Germany), DirexGroup (United States), Cook Medical LLC. (United States), Stryker Corporation (United States) and Medtronic plc (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing as the Escalating Incidence of Kidney Disorder" is seen as one of major influencing trends for Dent Disease Treatment Market during projected period 2022-202.
The Dent Disease Treatment market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Dent Disease Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Rhinoplasty Comprehensive Study by Type (Closed Rhinoplasty hidden inside the nose., Open Rhinoplasty, Filler Rhinoplasty, Revision Rhinoplasty), Application (Power setting of the console,, Density o...
$ 3450
Oculoplastic Surgery Comprehensive Study by Type (Blepharoplasty, Ptosis Repair, Entropion and Ectropion Repai), Application (Patient Education and Information Apps, Surgical Simulation and Training ...
$ 3500
Chromhidrosis Treatment Comprehensive Study by Type (Botox, Liposuction, Surgery, Home remedies, Others), Application (Hospitals and Clinics, Specialty and Dermatology Clinics, Others), Chromhidrosis...
$ 3450
Sezary Syndrome Comprehensive Study by Application (Hospitals, Specialty Clinics), Drug (Vorinostat, Mogamulizumab, Others), Treatment (Standard Treatment (Photodynamic Therapy, Radiation Therapy, Ch...
$ 3650
Neglected Tropical Diseases Comprehensive Study by Therapy (Drugs, Vaccines, Bandages, Injections, Others), Disease (Buruli Ulcer, Chagas Disease, Cysticercosis, Dengue Fever, Others), Age (Adults, C...
$ 3450
Idiopathic Hypersomnia Treatment  Comprehensive Study by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), Treatment Type (Prescription Medications (Stimulant Medications, Sodium...
$ 3650